Condition
Postmastectomy Syndrome
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Qutenza 179 Mg Cutaneous Patch
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 4 (1)
Trial Status
Unknown1
Clinical Trials (1)
Research Network
Common Treatments
- Qutenza 179 Mg Cutaneous Patch1
- Clostridium Botulinum Neurotoxin Type A 150kd Free Of Complexing Proteins1
Active Sponsors
- Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana1